The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADVERUM BIOTECHNOLOGIES INC | COM NEW | 00773U207 | 7,659,157 | 541,666 | SH | SOLE | 541,666 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 8,056,147 | 357,733 | SH | SOLE | 357,733 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 16,984,964 | 665,555 | SH | SOLE | 665,555 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 17,499,269 | 319,972 | SH | SOLE | 319,972 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 20,870,422 | 497,270 | SH | SOLE | 497,270 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 14,068,500 | 1,245,000 | SH | SOLE | 1,245,000 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 1,043,750 | 1,134,511 | SH | SOLE | 1,134,511 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 5,311,757 | 790,440 | SH | SOLE | 790,440 | 0 | 0 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 37,260,870 | 1,242,029 | SH | SOLE | 1,242,029 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 67,474,800 | 3,835,975 | SH | SOLE | 3,835,975 | 0 | 0 | ||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 62,466,730 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 6,104,609 | 572,665 | SH | SOLE | 572,665 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 5,846,400 | 1,305,000 | SH | SOLE | 1,305,000 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 24,713,590 | 548,825 | SH | SOLE | 548,825 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 14,180,582 | 282,313 | SH | SOLE | 282,313 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 18,432,536 | 797,600 | SH | SOLE | 797,600 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 20,746,800 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
Q32 BIO INC | COM | 746964105 | 4,293,978 | 251,994 | SH | SOLE | 251,994 | 0 | 0 | ||
RALLYBIO CORP | COM | 75120L100 | 6,716,839 | 3,630,724 | SH | SOLE | 3,630,724 | 0 | 0 | ||
SCPHARMACEUTICALS INC | COM | 810648105 | 6,027,248 | 1,200,647 | SH | SOLE | 1,200,647 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 10,285,920 | 476,200 | SH | SOLE | 476,200 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 15,404,487 | 939,298 | SH | SOLE | 939,298 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 19,479,920 | 237,560 | SH | SOLE | 237,560 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 12,897,778 | 736,595 | SH | SOLE | 736,595 | 0 | 0 | ||
VOR BIOPHARMA INC | COM | 929033108 | 15,077,284 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 7,722,400 | 490,000 | SH | SOLE | 490,000 | 0 | 0 |